Insights

Aggressive Innovation Leverage Enko's pharma-inspired plant discovery approach and recent AI-based platform recognition to position high-value, science-driven crop protection solutions that address pest resistance and new diseases.

Strategic Partnerships Target collaborations with Syngenta and other large agri-chemical players to accelerate co-development of novel chemistries, expanding Enko's reach into major crop segments and regional markets.

Awarded Credibility Use the AI-based AgTech Platform of the Year accolade to build credibility with potential customers, investors, and distributors, facilitating faster engagement and trial adoption.

Sustainability Focus Highlight safe and sustainable solutions tailored to reduce pest resistance and disease pressure, aligning with grower demand for environmentally responsible products and compliant supply chains.

Growth Readiness Capitalize on substantial funding and a mid-sized specialized team to propose scalable solutions, pilot programs, and flexible licensing or co-development deals to farmers and agribusinesses seeking innovative tools.

Similar companies to Enko®

Enko® Tech Stack

Enko® uses 8 technology products and services including Amazon Web Services, Docker, PostgreSQL, and more. Explore Enko®'s tech stack below.

Media & News

Enko®'s Email Address Formats

Enko® uses at least 3 email formats:
Enko® Email FormatsExamplePercentage
First_Last@enko.agJohn_Doe@enko.ag
100%
First.Last@enkochem.comJohn.Doe@enkochem.com
98%
Fir.Last@enkochem.comJoh.Doe@enkochem.com
2%

Frequently Asked Questions

What is Enko®'s stock symbol?

Minus sign iconPlus sign icon
Enko® is a publicly traded company; the company's stock symbol is CNKS.L.

What is Enko®'s official website and social media links?

Minus sign iconPlus sign icon
Enko®'s official website is enko.ag and has social profiles on LinkedIn.

How much revenue does Enko® generate?

Minus sign iconPlus sign icon
As of October 2026, Enko®'s annual revenue is estimated to be $10M - $25M.

What is Enko®'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Enko®'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Enko® have currently?

Minus sign iconPlus sign icon
As of October 2026, Enko® has approximately 56 employees across 3 continents, including North America, Europe and South America. Key team members include Chief Executive Officer: A. K., Vice President Finance: S. P. S. and Company Owner: A. P. Explore Enko®'s employee directory with LeadIQ.

What industry does Enko® belong to?

Minus sign iconPlus sign icon
Enko® operates in the Biotechnology Research industry.

What technology does Enko® use?

Minus sign iconPlus sign icon
Enko®'s tech stack includes Amazon Web Services, Docker, PostgreSQL, NetSuite, scikit-learn, Office 365, Webflow and Microsoft Teams.

What is Enko®'s email format?

Minus sign iconPlus sign icon
Enko®'s email format typically follows the pattern of First_Last@enko.ag. Find more Enko® email formats with LeadIQ.

How much funding has Enko® raised to date?

Minus sign iconPlus sign icon
As of October 2026, Enko® has raised $135M in funding. The last funding round occurred on Jan 31, 2023.

When was Enko® founded?

Minus sign iconPlus sign icon
Enko® was founded in 2017.
Enko® logo

Enko®

Biotechnology ResearchConnecticut, United States51-200 Employees

Enko is a biotechnology research company that designs safe and sustainable solutions to protect crops from threats such as pests and diseases. By adapting drug discovery and development approaches from pharma to plants, it aims to accelerate the discovery and deployment of crop protection, offering an innovation model intended to meet evolving farming needs.

Section iconCompany Overview

Website
enko.ag
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CNKS.L
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $135M

    Enko® has raised a total of $135M of funding over 5 rounds. Their latest funding round was raised on Jan 31, 2023 as a Series C.

  • $10M - $25M

    Enko®'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.